mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.005 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.006 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.007 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.008 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.008 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.008 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.008 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.009 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |